Warner Chilcott (NASDAQ:WCRX) Getting Ready to Post Quarterly Results; Held...
Specialty pharmaceutical company Warner Chilcott Plc (NASDAQ:WCRX) reported that it will provide its fiscal Q4 and full year 2012 financial results earlier to the market opening on Friday, February 22,...
View ArticleToll Brothers (NYSE:TOL) and Actavis, Inc.’s (NYSE:ACT) on Earnings Front...
Toll Brothers (NYSE:TOL) jumped back to a profit in initial quarter, but still was below Wall Street targets and shares declined ahead of the opening bell of regular Wednesday session. For the quarter...
View ArticleWarner Chilcott (NASDAQ:WCRX) Beats Fiscal Fourth Quarter Results – WCRX,...
The Dublin, Ireland-based Warner Chilcott Plc (NASDAQ:WCRX) announced fiscal Q4 profit hiked from previous year, showing lower costs and sales expenses in many key promoted products, mainly LO Loestrin...
View ArticleMylan (NASDAQ:MYL) Profit Soars 25% on Revenue Gains; Plans to Acquire Agila...
Mylan Inc (NASDAQ:MYL) on Wednesday reported fiscal Q4 earnings moved up 25% as the world’s third-biggest generic-drug maker by sales announced revenue gains and declared plans to purchase Agila...
View ArticleClik here to view.
Actavis Inc. (NYSE:ACT) Plans to Buy Warner Chilcott (NASDAQ:WCRX) in Swap Deal
Actavis Inc. (NYSE:ACT) would purchase Warner Chilcott (NASDAQ:WCRX) in a stock swap that prices the specialty pharmaceutical company at $8.5 billion, the firms declared Monday. According to the terms...
View ArticleHealthcare Giant News Buzz: Actavis (NYSE:ACT), Warner Chilcott (NASDAQ:WCRX)...
Investors responded negatively to the healthcare stocks on Monday. Key movement were observed in Theravance Inc (NASDAQ:THRX) and Halozyme Therapeutics, Inc (NASDAQ:HALO) on percentage decliners side...
View Article
